Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

Peer Review reports

Original Submission
14 Feb 2013	Submitted	Original manuscript
22 Apr 2013	Author responded	Author comments - odile launay
Resubmission - Version 2
22 Apr 2013	Submitted	Manuscript version 2
25 Apr 2013	Author responded	Author comments - odile launay
Resubmission - Version 3
25 Apr 2013	Submitted	Manuscript version 3
17 Jun 2013	Reviewed	Reviewer Report - Helen Oh
18 Jun 2013	Reviewed	Reviewer Report - Istvan Jankovics
17 Jul 2013	Author responded	Author comments - odile launay
Resubmission - Version 4
17 Jul 2013	Submitted	Manuscript version 4
Publishing
28 Aug 2013	Editorially accepted
16 Sep 2013	Article published	10.1186/1471-2334-13-435

Back to article page